Overview

osteoprotegerin


Related Overviews

 

'osteoprotegerin' can also refer to...

osteoprotegerin

osteoprotegerin

Serum osteoprotegerin and renal osteodystrophy

Effects of osteoprotegerin administration on osteoclast differentiation and trabecular bone structure in osteoprotegerin-deficient mice

Defective bone remodelling in osteoprotegerin-deficient mice

Osteoprotegerin as biomarker for persistence of rheumatoid arthritis

Circulating osteoprotegerin is not removed through haemodialysis membrane

SERUM OSTEOPROTEGERIN AND RANKL LEVELS IN CHRONIC ALCOHOLIC LIVER DISEASE

Cardiac hypertrophy is exacerbated in aged mice lacking the osteoprotegerin gene

Osteoprotegerin is associated with hip fracture incidence: the Tromsø Study

200 Autoantibodies to Osteoprotegerin and Bone Mineral Density in Axial Spondyloarthritis

Osteoprotegerin genetic polymorphisms and age of symptom onset in ankylosing spondylitis

Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis

P-009A: Osteoprotegerin: a novel alarmin in colonic epithelial cells?

Osteoprotegerin administration reduces femural bone loss in ovariectomized mice via impairment of osteoclast structure and function

Osteoclast differentiation and characteristic trabecular bone formation during growth plate destruction in osteoprotegerin-deficient mice

Osteoprotegerin protects endothelial cells against apoptotic cell death induced by Porphyromonas gingivalis cysteine proteinases

Expression and Identification of Mutated Osteoprotegerin in Culture Cells and Larvae of Silkworm

Interleukin 6, RANKL, and Osteoprotegerin Expression by Chikungunya Virus–Infected Human Osteoblasts

 

More Like This

Show all results sharing these subjects:

  • Chemistry
  • Medicine and Health

GO

Show Summary Details

Quick Reference

A soluble decoy receptor of the tumour necrosis factor (TNF) receptor superfamily (OPG, osteoclastogenesis inhibitory factor, OCIF, TNFRSF11B, 401 aa) that binds osteoclast differentiation factor/RANKL and inhibits the differentiation and function of osteoclasts and therefore bone destruction. Deficiency of OPG results in juvenile Paget's disease.

Subjects: Chemistry — Medicine and Health.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.